Nisoldipine

Chemical formula: C₂₀H₂₄N₂O₆  Molecular mass: 388.414 g/mol  PubChem compound: 4499

Active ingredient description

Nisoldipine is a member of the dihydropyridine class of calcium channel antagonists (calcium ion antagonists or slow channel blockers) that inhibit the transmembrane influx of calcium into vascular smooth muscle and cardiac muscle. Because the contractile process of vascular smooth muscle is dependent upon the movement of extracellular calcium into the muscle through specific ion channels, inhibition of the calcium channel results in dilation of the arterioles.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
C08CA07 Nisoldipine C Cardiovascular system → C08 Calcium channel blockers → C08C Selective calcium channel blockers with mainly vascular effects → C08CA Dihydropyridine derivatives
Discover more medicines within C08CA07

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 63675-72-9
DrugBank Drug: DB00401
KEGG Drug: D00618
PubChem Compound: 4499
RxNorm Ingredient: 7435
SNOMED-CT Concept: 386861009
Nisoldipine (substance)
UNII Identifier: 4I8HAB65SZ
NISOLDIPINE

Medicines

Nisoldipine is an active ingredient of these brands:

United States (US)

South Africa (ZA)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.